QBTS expects modest Q2 growth as revenue timing, RPOs and system transactions shape its 2026 recognition pattern, with more revenues in H2.
D-WAVE QUANTUM (QBTS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
QBTS raises its system sales outlook after record bookings and surging demand, with bigger deals and recurring revenue expected to support growth.
QBTS gets a $1.5M NSF grant to support fault-tolerant quantum computing research, extending U.S. government backing as it advances dual-rail technology.
D-Wave and Rigetti have both pulled back in 2026, but commercial progress and execution could shape which quantum player stands out next.
QBTS advances its gate-model roadmap with a first-of-its-kind error-aware quantum simulator, with developer access set for September 2026.
QBTS is drawing comparisons to NVIDIA as D-Wave expands its quantum ambitions, but a rich valuation raises the stakes for future execution.
QBTS expands into AI and blockchain via a live quantum-classical testNet with Postquant Labs and early drug discovery gains with Shionogi.
D-WAVE QUANTUM (QBTS) reported earnings 30 days ago. What's next for the stock?
D-Wave Quantum (NYSE:QBTS) came public through a
D-Wave Quantum Inc. (QBTS) Analyst/Investor Day Transcript
Just days after the announcement of a $2 billion funding injection for the quantum computing industry from the U.S. Department of Commerce, including plans for $100 million to go toward D-Wave's continued development of its two-pronged technological approach, the company revealed another bit of support from the government.